Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

Below is Validea's guru fundamental report for GLOBUS MEDICAL INC (GMED). Of the 22 guru strategies we follow, GMED rates highest using our Value Investor model based on the published strategy of ...

Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, the challenging macroeconomic scenario continues to plague Globus Medical.

NYSE GMED opened at $76.65 on Wednesday. The firm has a market capitalization of $10.54 billion, a price-to-earnings ratio of 102.20, a PEG ratio of 1.61 and a beta of 1.19. Globus Medical, Inc ...

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...